1Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular prlfiling of cancer[ J]. Hum mol Genet,2001,10(7) :657 - 662.
2Kononen J, Bubendorf L, Kallioniemi A, et al.Tissue microarrays for high-throughput molecular profilling of tumor specimens[ J] .Nat Med, 1988,4(7) :844 - 847.
3Moch H, Kononen T, Kallioniemi OP, et al, Tissue microarrays: what will they bring to molecular and anatomic pathology[J] .Adv Anat Pathol, 2001,8 ( 1 ) : 14 - 20.
4Simon R,Sauter G.Tissue microarrays for miniaturized high-throughput molecular profiling of tumors[J] .Exp Hematol,2002,30( 12): 1365 - 1372.
6Camp RL, Chasrette LA, Rinan DL. Validation of tissue microarray technology in breast carcinoma[J]. Lab Invest,2000,80(12) : 1943 - 1949.
7Hsu FD, Nielsen TO, Alkushi A,et al.Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry[ J]. Mod Pathol,2(D2,15(12) : 1374 - 1380.
8Wang Y, Wu MC,Sham JS,et al.Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma.A broad survey using high-throughpu tissue microarray[ J]. Cancer, 2002,95 ( 11 ):2346 - 2352.
9Gillett CE,Springall RJ, Barnes DM,et al.Mutiple tissue corearrays in histopaholgy research: a validation study [ J ]. J Pathol, 2002, 192 (4) : 549 - 553.
10Barlund M, Monni O, Kononen J, et al. Multiple genes at 17q23 undergo amplification and overexpression in breas cancer[ J]. Cancer Res,2000, 60(19) :5340 - 5344.
